Ducommun (DCO) Financials

$56.62 +0.22 (+0.40%)

Closing price 04/15/2025 03:59 PM Eastern

Extended Trading

$56.62 0.00 (-0.01%)

As of 06:48 AM Eastern

Annual Income Statements for Ducommun

This table shows Ducommun's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	20	-75	25	20	9.04	32	29	136	29	16	31
Consolidated Net Income / (Loss)	20	-75	25	20	9.04	32	29	136	29	16	31
Net Income / (Loss) Continuing Operations	20	-75	25	20	9.04	32	29	136	29	16	31
Total Pre-Tax Income	26	-107	38	7.61	10	38	32	170	33	16	37
Total Operating Income	52	-75	29	16	24	56	46	49	40	29	52
Total Gross Profit	140	101	107	103	123	152	138	142	144	163	197
Total Revenue	742	666	551	558	629	721	629	645	713	757	787
Operating Revenue	742	666	551	558	629	721	629	645	713	757	787
Total Cost of Revenue	602	565	444	455	507	569	491	503	568	594	589
Operating Cost of Revenue	602	565	444	455	507	569	491	503	568	594	589
Total Operating Expenses	89	176	77	87	99	96	92	94	105	134	145
Selling, General & Admin Expense	89	84	77	79	84	96	90	94	98	120	139
Restructuring Charge	-	2.13	0.18	8.36	15	0.00	2.42	0.00	6.16	15	6.44
Total Other Income / (Expense), net	-26	-31	8.90	-8.03	-14	-18	-14	122	-6.47	-13	-15
Interest Expense	28	33	8.92	8.87	14	18	14	11	0.30	0.00	0.00
Interest & Investment Income	-	-	-	-	-	-	0.00	133	-12	-21	-15
Other Income / (Expense), net	2.55	2.15	18	0.85	0.30	0.00	0.13	0.27	5.40	8.24	0.00
Income Tax Expense	6.37	-32	13	-12	1.24	5.30	2.81	35	4.53	0.45	5.41
Basic Earnings per Share	$1.82	($6.78)	$2.27	$1.78	$0.79	$2.82	$2.50	$11.41	$2.38	$1.16	$2.13
Weighted Average Basic Shares Outstanding	10.90M	11.05M	11.15M	11.29M	11.39M	11.52M	11.68M	11.88M	12.07M	13.72M	14.77M
Diluted Earnings per Share	$1.79	($6.78)	$2.24	$1.74	$0.77	$2.75	$2.45	$11.06	$2.33	$1.14	$2.10
Weighted Average Diluted Shares Outstanding	11.13M	11.05M	11.30M	11.56M	11.66M	11.79M	11.93M	12.25M	12.37M	13.97M	15.01M
Weighted Average Basic & Diluted Shares Outstanding	10.90M	11M	11.10M	11.30M	11.43M	11.61M	11.76M	11.97M	12.15M	14.64M	14.81M

This table shows Ducommun's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	8.46	8.08	5.23	2.37	3.21	5.11	6.85	7.72	10	6.77
Consolidated Net Income / (Loss)	8.46	8.08	5.23	2.37	3.21	5.11	6.85	7.72	10	6.77
Net Income / (Loss) Continuing Operations	8.46	8.08	5.23	2.37	3.21	5.11	6.85	7.72	10	6.77
Total Pre-Tax Income	9.92	8.58	6.04	3.33	3.24	3.77	8.74	9.95	11	6.78
Total Operating Income	13	9.69	6.37	5.01	8.61	8.93	13	14	15	10
Total Gross Profit	39	39	37	40	45	42	47	51	53	46
Total Revenue	187	188	181	187	196	192	191	197	201	197
Operating Revenue	187	188	181	187	196	192	191	197	201	197
Total Cost of Revenue	148	150	144	147	152	151	144	146	149	151
Operating Cost of Revenue	148	150	144	147	152	151	144	146	149	151
Total Operating Expenses	25	29	30	35	36	33	34	37	37	36
Selling, General & Admin Expense	25	26	26	30	32	31	33	36	35	34
Restructuring Charge	0.57	2.89	4.17	4.77	3.81	1.79	1.37	1.25	1.92	1.90
Total Other Income / (Expense), net	-3.29	-1.12	-0.33	-1.68	-5.37	-5.16	-3.88	-3.98	-3.83	-3.62
Income Tax Expense	1.46	0.50	0.81	0.96	0.03	-1.34	1.89	2.23	1.29	0.01
Basic Earnings per Share	$0.70	$0.66	$0.43	$0.18	$0.22	$0.33	$0.47	$0.52	$0.69	$0.45
Weighted Average Basic Shares Outstanding	12.11M	12.07M	12.20M	13.40M	14.63M	13.72M	14.69M	14.78M	14.81M	14.77M
Diluted Earnings per Share	$0.69	$0.64	$0.42	$0.17	$0.22	$0.33	$0.46	$0.52	$0.67	$0.45
Weighted Average Diluted Shares Outstanding	12.35M	12.37M	12.54M	13.60M	14.81M	13.97M	14.94M	14.96M	15.04M	15.01M
Weighted Average Basic & Diluted Shares Outstanding	12.10M	12.15M	12.24M	14.57M	14.60M	14.64M	14.72M	14.75M	14.78M	14.81M

This table details how cash moves in and out of Ducommun's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-3.19	-40	1.98	-5.28	8.11	29	17	20	-30	-3.38	-5.72
Net Cash From Operating Activities	53	24	43	35	46	51	13	-0.57	33	31	34
Net Cash From Continuing Operating Activities	53	24	43	35	46	51	13	-0.57	33	31	34
Net Income / (Loss) Continuing Operations	20	-75	25	20	9.04	32	29	136	29	16	31
Consolidated Net Income / (Loss)	20	-75	25	20	9.04	32	29	136	29	16	31
Depreciation Expense	29	27	23	23	25	28	29	28	31	33	33
Amortization Expense	-	-	-	0.00	0.00	2.67	3.16	3.35	7.27	8.22	8.51
Non-Cash Adjustments To Reconcile Net Income	-5.88	104	-23	7.21	-64	-18	-19	-137	-3.16	23	-31
Changes in Operating Assets and Liabilities, net	10	-32	19	-15	76	5.55	-29	-31	-32	-49	-8.43
Net Cash From Investing Activities	-15	-13	35	-86	-48	-95	-5.47	58	-19	-133	-14
Net Cash From Continuing Investing Activities	-15	-13	35	-86	-48	-95	-5.47	58	-19	-133	-14
Purchase of Property, Plant & Equipment	-18	-16	-17	-28	-18	-18	-13	-17	-20	-20	-14
Acquisitions	-	0.00	0.00	-60	-31	-77	0.00	-69	0.37	-114	0.00
Sale of Property, Plant & Equipment	0.09	0.90	0.02	0.91	0.40	0.00	0.01	0.55	0.08	0.40	0.22
Net Cash From Financing Activities	-41	-50	-76	45	9.81	73	9.74	-37	-44	99	-26
Net Cash From Continuing Financing Activities	-41	-50	-76	45	9.81	73	9.74	-37	-44	99	-26
Repayment of Debt	-43	-390	-147	-348	-525	-363	-56	-129	-296	-159	-43
Issuance of Debt	0.00	340	72	396	536	438	66	96	254	177	20
Issuance of Common Equity	-	-	-	-	-	-	-	0.00	0.00	85	0.00
Other Financing Activities, net	1.50	-0.50	-1.18	-2.61	-1.55	-2.47	-0.61	-4.05	-1.38	-3.28	-2.86

This table details how cash moves in and out of Ducommun's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-16	25	-29	5.69	4.39	16	-11	-2.66	7.86	-0.13
Net Cash From Operating Activities	-5.49	32	-19	9.18	14	26	-1.65	3.46	14	18
Net Cash From Continuing Operating Activities	-5.49	32	-19	9.18	14	26	-1.65	3.46	14	18
Net Income / (Loss) Continuing Operations	8.46	8.08	5.23	2.37	3.21	5.11	6.85	7.72	10	6.77
Consolidated Net Income / (Loss)	8.46	8.08	5.23	2.37	3.21	5.11	6.85	7.72	10	6.77
Depreciation Expense	7.67	8.09	7.99	7.95	8.48	8.15	8.35	8.25	8.53	8.31
Amortization Expense	1.60	2.08	1.97	0.99	3.03	2.23	2.07	2.09	2.17	2.18
Non-Cash Adjustments To Reconcile Net Income	-14	18	-12	1.64	20	14	-13	-17	-21	20
Changes in Operating Assets and Liabilities, net	-9.61	-4.24	-22	-3.77	-21	-2.90	-6.06	2.18	15	-19
Net Cash From Investing Activities	-5.30	-5.29	-5.36	-120	-4.73	-3.49	-4.97	-3.32	-1.99	-3.63
Net Cash From Continuing Investing Activities	-5.30	-5.29	-5.36	-120	-4.73	-3.49	-4.97	-3.32	-1.99	-3.63
Purchase of Property, Plant & Equipment	-5.30	-5.32	-5.36	-5.56	-5.11	-3.49	-4.97	-3.32	-1.99	-3.85
Sale of Property, Plant & Equipment	-	0.03	-	-	-	-	-	-	-	0.22
Net Cash From Financing Activities	-5.49	-1.76	-4.84	116	-5.20	-7.34	-4.18	-2.81	-4.09	-15
Net Cash From Continuing Financing Activities	-5.49	-1.76	-4.84	116	-5.20	-7.34	-4.18	-2.81	-4.09	-15
Repayment of Debt	-261	-1.66	-9.15	-94	-26	-31	-12	-12	-5.07	-15
Other Financing Activities, net	1.31	-0.10	-3.19	-0.85	1.45	-0.69	-2.53	-1.16	0.98	-0.15

This table presents Ducommun's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	748	557	515	567	31	790	837	979	1,022	1,121	1,126
Total Current Assets	329	263	226	221	6.32	341	410	493	527	550	568
Cash & Equivalents	46	5.45	7.43	2.15	-	40	56	76	46	43	37
Accounts Receivable	91	77	76	74	-	67	58	72	104	105	110
Inventories, net	143	115	120	122	-	112	129	151	171	199	197
Other Current Assets	35	24	22	23	6.32	122	167	193	206	203	224
Plant, Property, & Equipment, net	99	97	102	110	0.00	115	110	102	106	111	110
Total Noncurrent Assets	320	197	188	235	25	334	317	384	388	460	448
Goodwill	158	83	83	117	-	171	171	204	203	245	245
Intangible Assets	155	111	102	115	-	138	125	142	127	166	150
Noncurrent Deferred & Refundable Income Taxes	-	0.32	0.29	0.26	0.31	0.06	0.03	-	0.00	0.64	2.24
Other Noncurrent Operating Assets	7.12	3.77	3.49	3.10	24	25	21	38	57	48	52
Total Liabilities & Shareholders' Equity	748	557	515	567	270	790	837	979	1,022	1,121	1,126
Total Liabilities	491	371	303	331	90	498	508	504	496	485	444
Total Current Liabilities	111	84	86	80	40	145	143	163	199	184	175
Short-Term Debt	0.03	0.03	0.00	0.00	-	7.00	7.00	7.00	6.25	7.81	13
Accounts Payable	59	40	57	52	-	83	64	66	90	72	76
Accrued Expenses	52	36	29	28	37	38	41	41	49	42	44
Current Deferred Revenue	-	-	-	-	-	-	-	-	47	53	34
Other Current Liabilities	-	-	-	0.00	2.54	17	31	48	7.16	7.87	8.53
Total Noncurrent Liabilities	380	288	217	251	50	353	365	342	296	301	268
Long-Term Debt	290	241	167	216	-	301	312	279	241	257	230
Noncurrent Deferred & Payable Income Tax Liabilities	69	28	31	16	18	17	17	19	14	4.77	0.00
Other Noncurrent Operating Liabilities	20	19	19	19	32	35	36	43	42	39	38
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	257	186	212	236	180	293	329	475	526	636	683
Total Preferred & Common Equity	257	186	212	236	180	293	329	475	526	636	683
Total Common Equity	257	186	212	236	180	293	329	475	526	636	683
Common Stock	72	75	77	80	-	89	97	104	112	206	218
Retained Earnings	191	116	141	161	180	213	242	377	406	422	453
Accumulated Other Comprehensive Income / (Loss)	-6.65	-5.60	-6.08	-6.12	-	-8.27	-9.60	-7.03	7.75	7.77	11

This table presents Ducommun's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	990	1,006	1,119	1,142	1,132	1,132	1,130
Total Current Assets	499	515	529	557	564	569	570
Cash & Equivalents	21	17	23	27	32	29	37
Accounts Receivable	94	96	95	105	104	107	108
Inventories, net	172	194	204	215	209	202	186
Other Current Assets	211	208	206	210	218	231	240
Plant, Property, & Equipment, net	106	107	111	112	112	111	110
Total Noncurrent Assets	385	384	478	474	456	451	450
Goodwill	203	203	245	245	245	245	245
Intangible Assets	131	124	175	171	162	158	154
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	0.64	0.64	5.11
Other Noncurrent Operating Assets	50	57	59	58	49	48	46
Total Liabilities & Shareholders' Equity	990	1,006	1,119	1,142	1,132	1,132	1,130
Total Liabilities	481	478	497	507	487	476	464
Total Current Liabilities	181	181	167	190	189	186	178
Short-Term Debt	6.25	6.25	6.25	6.25	9.38	11	11
Accounts Payable	90	99	83	78	84	77	75
Accrued Expenses	44	29	38	46	29	40	46
Current Deferred Revenue	-	-	-	51	58	50	37
Other Current Liabilities	41	47	40	8.00	7.75	7.94	8.33
Total Noncurrent Liabilities	299	296	329	317	298	290	287
Long-Term Debt	242	239	271	265	254	251	246
Noncurrent Deferred & Payable Income Tax Liabilities	14	12	12	11	4.44	2.95	0.50
Other Noncurrent Operating Liabilities	43	45	46	41	40	36	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	509	528	622	635	646	656	666
Total Preferred & Common Equity	509	528	622	635	646	656	666
Total Common Equity	509	528	622	635	646	656	666
Common Stock	110	111	200	205	207	209	214
Retained Earnings	398	411	414	417	429	437	447
Accumulated Other Comprehensive Income / (Loss)	0.67	5.66	8.81	13	10	10	5.25

This table displays calculated financial ratios and metrics derived from Ducommun's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.73%	-10.25%	-17.32%	1.37%	12.74%	14.58%	-12.78%	2.62%	10.40%	6.24%	3.90%
EBITDA Growth	18.67%	-155.57%	250.91%	-43.74%	25.92%	76.12%	-10.97%	4.18%	3.70%	-7.08%	20.82%
EBIT Growth	38.20%	-234.69%	164.29%	-64.96%	46.98%	132.17%	-18.85%	7.70%	-8.06%	-17.78%	40.53%
NOPAT Growth	-17.74%	-234.50%	136.73%	113.03%	-49.00%	129.75%	-14.12%	-6.39%	-11.54%	-18.20%	58.44%
Net Income Growth	74.61%	-476.90%	133.74%	-20.52%	-55.00%	259.28%	-10.13%	364.58%	-78.76%	-44.67%	97.73%
EPS Growth	70.48%	-478.77%	133.04%	-22.32%	-55.75%	257.14%	-10.91%	351.43%	-78.93%	-51.07%	84.21%
Operating Cash Flow Growth	16.23%	-55.68%	82.74%	-18.11%	30.49%	10.37%	-75.29%	-104.48%	5,884.07%	-4.94%	10.02%
Free Cash Flow Firm Growth	-21.04%	10.31%	-45.46%	-208.14%	1,543.00%	-207.98%	101.89%	-599.03%	86.09%	-1,275.17%	114.36%
Invested Capital Growth	-3.31%	-22.93%	-3.77%	20.97%	-113.03%	1,058.05%	5.47%	15.69%	6.12%	18.09%	3.46%
Revenue Q/Q Growth	-0.05%	-4.45%	-2.50%	-0.04%	3.61%	3.26%	-4.43%	1.11%	3.40%	0.53%	0.65%
EBITDA Q/Q Growth	11.00%	-191.50%	377.46%	-22.00%	25.74%	16.67%	-4.63%	0.74%	2.86%	-3.30%	1.39%
EBIT Q/Q Growth	24.28%	-413.24%	195.23%	-40.78%	60.93%	18.80%	-7.05%	1.02%	0.46%	-7.18%	2.31%
NOPAT Q/Q Growth	24.25%	-422.44%	140.10%	103.00%	-73.23%	25.34%	-2.33%	-11.98%	3.76%	6.21%	-0.23%
Net Income Q/Q Growth	62.29%	-1,545.69%	159.09%	49.50%	-49.37%	33.79%	2.75%	294.52%	-78.11%	-15.72%	5.58%
EPS Q/Q Growth	64.22%	-1,553.66%	157.29%	48.72%	-50.00%	34.15%	2.51%	290.81%	-78.29%	-21.38%	6.06%
Operating Cash Flow Q/Q Growth	2.68%	-47.07%	10.48%	-17.70%	11.47%	55.09%	-61.18%	52.16%	164.92%	-15.17%	-19.10%
Free Cash Flow Firm Q/Q Growth	0.15%	49.68%	-52.09%	18.22%	1,204.46%	-3,268.46%	122.65%	-363.26%	86.27%	11.78%	-61.83%
Invested Capital Q/Q Growth	-4.11%	-22.35%	-1.75%	1.38%	-112.17%	11.79%	-0.07%	5.66%	-1.26%	-2.44%	0.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	18.91%	15.13%	19.35%	18.48%	19.48%	21.11%	21.90%	22.07%	20.25%	21.56%	25.08%
EBITDA Margin	11.23%	-6.95%	12.69%	7.05%	7.87%	12.09%	12.34%	12.53%	11.77%	10.30%	11.97%
Operating Margin	6.98%	-11.31%	5.31%	2.80%	3.80%	7.80%	7.24%	7.57%	5.58%	3.82%	6.64%
EBIT Margin	7.32%	-10.99%	8.54%	2.95%	3.85%	7.80%	7.26%	7.62%	6.34%	4.91%	6.64%
Profit (Net Income) Margin	2.68%	-11.24%	4.59%	3.60%	1.44%	4.50%	4.64%	21.00%	4.04%	2.10%	4.00%
Tax Burden Percent	75.71%	70.25%	66.28%	263.86%	87.97%	85.96%	91.22%	79.50%	86.40%	97.25%	85.34%
Interest Burden Percent	48.31%	145.69%	81.03%	46.17%	42.41%	67.15%	70.08%	346.87%	73.74%	44.09%	70.69%
Effective Tax Rate	24.29%	0.00%	33.72%	-163.86%	12.03%	14.04%	8.78%	20.50%	13.60%	2.75%	14.66%
Return on Invested Capital (ROIC)	7.69%	-11.89%	5.11%	10.05%	10.76%	19.24%	7.20%	6.09%	4.87%	3.55%	5.10%
ROIC Less NNEP Spread (ROIC-NNEP)	0.38%	-21.85%	8.39%	-1.29%	107.76%	-87.88%	2.55%	47.01%	2.15%	-2.22%	-1.01%
Return on Net Nonoperating Assets (RNNOA)	0.40%	-21.97%	7.59%	-1.08%	-6.42%	-5.51%	2.18%	27.63%	0.88%	-0.81%	-0.33%
Return on Equity (ROE)	8.10%	-33.86%	12.70%	8.97%	4.35%	13.73%	9.38%	33.72%	5.75%	2.74%	4.78%
Cash Return on Invested Capital (CROIC)	11.06%	14.02%	8.95%	-8.93%	0.00%	-101.82%	1.88%	-8.46%	-1.06%	-13.04%	1.70%
Operating Return on Assets (OROA)	7.19%	-11.22%	8.77%	3.05%	8.10%	13.69%	5.61%	5.41%	4.52%	3.47%	4.65%
Return on Assets (ROA)	2.63%	-11.48%	4.71%	3.71%	3.02%	7.90%	3.58%	14.93%	2.88%	1.49%	2.80%
Return on Common Equity (ROCE)	8.10%	-33.86%	12.70%	8.97%	4.35%	13.73%	9.38%	33.72%	5.75%	2.74%	4.78%
Return on Equity Simple (ROE_SIMPLE)	7.74%	-40.32%	11.91%	8.52%	5.02%	11.09%	8.86%	28.56%	5.47%	2.50%	4.61%
Net Operating Profit after Tax (NOPAT)	39	-53	19	41	21	48	42	39	34	28	45
NOPAT Margin	5.28%	-7.92%	3.52%	7.39%	3.34%	6.70%	6.60%	6.02%	4.82%	3.71%	5.66%
Net Nonoperating Expense Percent (NNEP)	7.32%	9.97%	-3.28%	11.34%	-96.99%	107.12%	4.65%	-40.92%	2.72%	5.77%	6.12%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	4.45%	3.12%	4.82%
Cost of Revenue to Revenue	81.09%	84.87%	80.65%	81.52%	80.52%	78.89%	78.10%	77.93%	79.75%	78.44%	74.92%
SG&A Expenses to Revenue	11.94%	12.58%	14.01%	14.18%	13.35%	13.31%	14.28%	14.50%	13.80%	15.82%	17.62%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.94%	26.44%	14.04%	15.68%	15.68%	13.31%	14.66%	14.50%	14.67%	17.74%	18.44%
Earnings before Interest and Taxes (EBIT)	54	-73	47	16	24	56	46	49	45	37	52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	83	-46	70	39	50	87	78	81	84	78	94
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.08	0.97	1.35	1.37	2.30	2.00	1.91	1.18	1.15	1.19	1.38
Price to Tangible Book Value (P/TBV)	0.00	0.00	10.21	93.28	2.30	0.00	18.63	4.32	3.10	3.38	3.26
Price to Revenue (P/Rev)	0.37	0.27	0.52	0.58	0.66	0.81	1.00	0.86	0.85	1.00	1.20
Price to Earnings (P/E)	13.93	0.00	11.31	16.05	45.87	18.00	21.56	4.11	21.00	47.71	29.87
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.18%	0.00%	8.84%	6.23%	2.18%	5.56%	4.64%	24.31%	4.76%	2.10%	3.35%
Enterprise Value to Invested Capital (EV/IC)	1.04	1.07	1.20	1.19	0.00	1.52	1.51	1.12	1.11	1.14	1.29
Enterprise Value to Revenue (EV/Rev)	0.70	0.62	0.81	0.96	0.66	1.18	1.42	1.19	1.13	1.30	1.46
Enterprise Value to EBITDA (EV/EBITDA)	6.25	0.00	6.37	13.64	8.37	9.78	11.48	9.49	9.60	12.60	12.17
Enterprise Value to EBIT (EV/EBIT)	9.59	0.00	9.46	32.54	17.11	15.16	19.54	15.62	17.82	26.43	21.95
Enterprise Value to NOPAT (EV/NOPAT)	13.30	0.00	22.98	13.00	19.70	17.64	21.48	19.76	23.42	34.91	25.72
Enterprise Value to Operating Cash Flow (EV/OCF)	9.76	17.53	10.29	15.13	8.96	16.71	70.69	0.00	24.64	31.60	33.53
Enterprise Value to Free Cash Flow (EV/FCFF)	9.25	6.68	13.13	0.00	0.78	0.00	82.36	0.00	0.00	0.00	77.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.13	1.30	0.79	0.92	0.00	1.05	0.97	0.60	0.47	0.42	0.36
Long-Term Debt to Equity	1.13	1.30	0.79	0.92	0.00	1.03	0.95	0.59	0.46	0.40	0.34
Financial Leverage	1.08	1.01	0.90	0.83	-0.06	0.06	0.85	0.59	0.41	0.36	0.32
Leverage Ratio	3.08	2.95	2.70	2.42	1.44	1.74	2.62	2.26	2.00	1.84	1.70
Compound Leverage Factor	1.49	4.30	2.18	1.12	0.61	1.17	1.83	7.84	1.47	0.81	1.20
Debt to Total Capital	53.06%	56.44%	44.04%	47.84%	0.00%	51.26%	49.20%	37.63%	31.94%	29.39%	26.20%
Short-Term Debt to Total Capital	0.00%	0.01%	0.00%	0.00%	0.00%	1.17%	1.08%	0.92%	0.81%	0.87%	1.35%
Long-Term Debt to Total Capital	53.06%	56.44%	44.04%	47.84%	0.00%	50.09%	48.12%	36.71%	31.13%	28.52%	24.85%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	46.94%	43.56%	55.96%	52.16%	100.00%	48.74%	50.80%	62.37%	68.06%	70.61%	73.80%
Debt to EBITDA	3.48	-5.20	2.39	5.49	0.00	3.53	4.11	3.54	2.94	3.40	2.57
Net Debt to EBITDA	2.93	-5.08	2.28	5.44	0.00	3.08	3.38	2.60	2.39	2.85	2.18
Long-Term Debt to EBITDA	3.48	-5.20	2.39	5.49	0.00	3.45	4.02	3.45	2.87	3.30	2.44
Debt to NOPAT	7.40	-4.57	8.62	5.24	0.00	6.37	7.68	7.37	7.18	9.42	5.44
Net Debt to NOPAT	6.24	-4.46	8.24	5.19	0.00	5.55	6.32	5.41	5.84	7.89	4.61
Long-Term Debt to NOPAT	7.40	-4.57	8.62	5.24	0.00	6.22	7.51	7.19	7.00	9.14	5.16
Altman Z-Score	2.28	1.73	2.64	2.36	32.45	2.53	2.46	2.43	2.52	2.64	3.11
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.96	3.15	2.62	2.75	0.16	2.36	2.87	3.03	2.64	2.99	3.24
Quick Ratio	1.23	0.99	0.97	0.95	0.00	0.74	0.80	0.91	0.75	0.80	0.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	56	62	34	-37	529	-571	11	-54	-7.51	-103	15
Operating Cash Flow to CapEx	296.71%	157.99%	254.74%	132.73%	268.49%	279.06%	100.85%	-3.46%	166.68%	162.50%	245.79%
Free Cash Flow to Firm to Interest Expense	2.01	1.86	3.80	-4.13	37.93	-30.93	0.79	-4.83	-25.47	0.00	0.00
Operating Cash Flow to Interest Expense	1.90	0.71	4.85	3.99	3.31	2.76	0.92	-0.05	110.78	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	1.26	0.26	2.95	0.99	2.08	1.77	0.01	-1.51	44.32	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.98	1.02	1.03	1.03	2.11	1.76	0.77	0.71	0.71	0.71	0.70
Accounts Receivable Turnover	8.11	7.92	7.18	7.43	0.00	0.00	10.05	9.91	8.09	7.26	7.34
Inventory Turnover	4.25	4.38	3.77	3.76	0.00	0.00	4.06	3.59	3.53	3.21	2.98
Fixed Asset Turnover	7.60	6.81	5.56	5.27	0.00	0.00	5.59	6.08	6.83	6.96	7.11
Accounts Payable Turnover	10.28	11.38	9.12	8.35	0.00	0.00	6.70	7.74	7.28	7.31	7.96
Days Sales Outstanding (DSO)	45.00	46.08	50.82	49.14	0.00	0.00	36.32	36.84	45.13	50.30	49.75
Days Inventory Outstanding (DIO)	85.94	83.38	96.69	97.08	0.00	0.00	89.80	101.66	103.46	113.84	122.67
Days Payable Outstanding (DPO)	35.51	32.07	40.01	43.69	0.00	0.00	54.46	47.19	50.17	49.91	45.85
Cash Conversion Cycle (CCC)	95.43	97.39	107.50	102.53	0.00	0.00	71.66	91.31	98.43	114.23	126.56
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	501	386	372	449	-59	561	592	685	727	858	888
Invested Capital Turnover	1.46	1.50	1.45	1.36	3.22	2.87	1.09	1.01	1.01	0.96	0.90
Increase / (Decrease) in Invested Capital	-17	-115	-15	78	-508	620	31	93	42	131	30
Enterprise Value (EV)	521	415	445	536	414	853	892	768	805	982	1,146
Market Capitalization	277	180	286	322	414	584	629	558	605	760	941
Book Value per Share	$23.44	$16.76	$18.98	$20.80	$15.78	$25.32	$28.11	$39.81	$43.46	$43.58	$46.18
Tangible Book Value per Share	($5.13)	($0.67)	$2.50	$0.31	$15.78	($1.43)	$2.88	$10.83	$16.14	$15.43	$19.51
Total Capital	547	426	379	452	180	601	648	761	773	901	925
Total Debt	290	241	167	216	0.00	308	319	286	247	265	242
Total Long-Term Debt	290	241	167	216	0.00	301	312	279	241	257	230
Net Debt	244	235	159	214	0.00	268	262	210	201	222	205
Capital Expenditures (CapEx)	18	15	17	27	17	18	13	16	20	19	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	172	174	132	139	-34	163	218	261	288	331	368
Debt-free Net Working Capital (DFNWC)	218	180	140	141	-34	203	274	337	334	374	405
Net Working Capital (NWC)	218	180	140	141	-34	196	267	330	328	366	393
Net Nonoperating Expense (NNE)	19	22	-5.90	21	12	16	12	-97	5.59	12	13
Net Nonoperating Obligations (NNO)	244	200	159	214	-239	268	262	210	201	222	205
Total Depreciation and Amortization (D&A)	29	27	23	23	25	31	32	32	39	41	42
Debt-free, Cash-free Net Working Capital to Revenue	23.19%	26.16%	24.01%	24.84%	-5.35%	22.67%	34.65%	40.39%	40.41%	43.70%	46.78%
Debt-free Net Working Capital to Revenue	29.34%	26.98%	25.36%	25.22%	-5.35%	28.16%	43.63%	52.22%	46.90%	49.36%	51.50%
Net Working Capital to Revenue	29.33%	26.97%	25.36%	25.22%	-5.35%	27.19%	42.51%	51.13%	46.02%	48.33%	49.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.82	($6.63)	$2.27	$1.78	$0.79	$2.82	$2.50	$11.41	$2.38	$1.16	$2.13
Adjusted Weighted Average Basic Shares Outstanding	10.90M	11.05M	11.15M	11.29M	11.39M	11.52M	11.68M	11.88M	12.07M	13.72M	14.77M
Adjusted Diluted Earnings per Share	$1.79	($6.63)	$2.24	$1.74	$0.77	$2.75	$2.45	$11.06	$2.33	$1.14	$2.10
Adjusted Weighted Average Diluted Shares Outstanding	11.13M	11.05M	11.30M	11.56M	11.66M	11.79M	11.93M	12.25M	12.37M	13.97M	15.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	10.96M	11.10M	11.20M	11.34M	11.43M	11.61M	11.76M	11.97M	12.15M	14.64M	14.81M
Normalized Net Operating Profit after Tax (NOPAT)	39	12	19	17	34	48	44	39	40	42	50
Normalized NOPAT Margin	5.28%	1.79%	3.54%	3.01%	5.39%	6.70%	6.95%	6.02%	5.57%	5.58%	6.36%
Pre Tax Income Margin	3.54%	-16.00%	6.92%	1.36%	1.63%	5.24%	5.08%	26.41%	4.68%	2.16%	4.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	1.93	-2.19	5.27	1.86	1.74	3.04	3.34	4.39	153.18	0.00	0.00
NOPAT to Interest Expense	1.40	-1.58	2.17	4.65	1.51	2.62	3.04	3.47	116.53	0.00	0.00
EBIT Less CapEx to Interest Expense	1.29	-2.64	3.37	-1.15	0.50	2.05	2.43	2.94	86.72	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.75	-2.03	0.27	1.64	0.27	1.63	2.12	2.02	50.06	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Ducommun's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	14.31%	14.21%	10.83%	7.53%	5.18%	2.11%	5.33%	5.17%	2.63%	2.63%
EBITDA Growth	3.22%	11.72%	-6.99%	3.52%	-10.55%	-11.94%	14.01%	34.76%	29.06%	6.57%
EBIT Growth	-2.52%	1.73%	-15.38%	16.89%	-34.86%	-23.76%	23.05%	53.62%	77.33%	12.78%
NOPAT Growth	-5.06%	-1.23%	-27.38%	-43.41%	-24.22%	32.50%	79.22%	202.87%	58.61%	-14.15%
Net Income Growth	-11.71%	-92.71%	-35.41%	-42.75%	-62.03%	-36.77%	30.93%	225.36%	215.84%	32.56%
EPS Growth	-11.54%	-92.92%	-36.36%	-50.00%	-68.12%	-48.44%	9.52%	205.88%	204.55%	36.36%
Operating Cash Flow Growth	-198.94%	173.79%	-0.41%	-63.23%	360.90%	-17.33%	91.29%	-62.29%	-2.63%	-30.47%
Free Cash Flow Firm Growth	-74.26%	60.83%	67.36%	-138.61%	-76.39%	-264.33%	-294.40%	99.71%	105.75%	83.80%
Invested Capital Growth	13.56%	6.12%	4.63%	23.16%	19.51%	18.09%	15.88%	1.29%	0.66%	3.46%
Revenue Q/Q Growth	7.11%	0.90%	-3.76%	3.38%	4.77%	-2.05%	-0.72%	3.22%	2.24%	-2.05%
EBITDA Q/Q Growth	29.30%	-1.00%	-9.20%	-10.93%	11.73%	-2.55%	17.56%	5.28%	7.01%	-19.53%
EBIT Q/Q Growth	70.45%	-8.50%	-15.18%	-11.64%	-5.02%	7.11%	36.88%	10.32%	9.64%	-31.88%
NOPAT Q/Q Growth	78.67%	-18.98%	-39.55%	-35.33%	139.27%	41.68%	-18.24%	9.28%	25.30%	-23.32%
Net Income Q/Q Growth	104.05%	-4.50%	-35.27%	-54.62%	35.34%	59.04%	34.03%	12.78%	31.38%	-33.25%
EPS Q/Q Growth	102.94%	-7.25%	-34.38%	-59.52%	29.41%	50.00%	39.39%	13.04%	28.85%	-32.84%
Operating Cash Flow Q/Q Growth	-121.98%	684.00%	-159.06%	148.50%	55.95%	85.05%	-106.22%	310.07%	302.72%	32.15%
Free Cash Flow Firm Q/Q Growth	-13.21%	57.22%	14.67%	-477.33%	16.31%	11.63%	7.63%	99.57%	1,748.18%	-349.01%
Invested Capital Q/Q Growth	3.34%	-1.26%	4.14%	15.91%	0.27%	-2.44%	2.19%	1.32%	-0.35%	0.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.68%	20.50%	20.29%	21.42%	22.73%	21.69%	24.60%	26.01%	26.15%	23.52%
EBITDA Margin	12.05%	11.83%	11.16%	9.61%	10.25%	10.20%	12.08%	12.32%	12.89%	10.59%
Operating Margin	7.08%	5.15%	3.52%	2.67%	4.39%	4.65%	6.61%	7.07%	7.58%	5.27%
EBIT Margin	7.08%	6.42%	5.66%	4.84%	4.39%	4.80%	6.61%	7.07%	7.58%	5.27%
Profit (Net Income) Margin	4.54%	4.29%	2.89%	1.27%	1.64%	2.66%	3.59%	3.92%	5.04%	3.43%
Tax Burden Percent	85.27%	94.20%	86.62%	71.31%	99.20%	135.47%	78.37%	77.64%	88.73%	99.88%
Interest Burden Percent	75.09%	70.94%	58.87%	36.73%	37.62%	40.91%	69.24%	71.45%	74.92%	65.22%
Effective Tax Rate	14.73%	5.80%	13.38%	28.69%	0.80%	-35.47%	21.63%	22.36%	11.27%	0.12%
Return on Invested Capital (ROIC)	6.02%	4.90%	3.01%	1.78%	4.06%	6.01%	4.87%	4.83%	5.96%	4.74%
ROIC Less NNEP Spread (ROIC-NNEP)	4.93%	4.39%	2.88%	1.27%	1.80%	2.71%	3.54%	3.56%	4.49%	3.05%
Return on Net Nonoperating Assets (RNNOA)	2.93%	1.80%	1.32%	0.54%	0.74%	0.98%	1.39%	1.36%	1.60%	0.99%
Return on Equity (ROE)	8.95%	6.70%	4.32%	2.32%	4.80%	7.00%	6.25%	6.18%	7.56%	5.73%
Cash Return on Invested Capital (CROIC)	-7.91%	-1.06%	-0.15%	-17.02%	-14.50%	-13.04%	-10.75%	3.17%	4.41%	1.70%
Operating Return on Assets (OROA)	5.34%	4.58%	4.21%	3.43%	3.10%	3.39%	4.74%	4.88%	5.21%	3.69%
Return on Assets (ROA)	3.42%	3.06%	2.15%	0.90%	1.16%	1.88%	2.57%	2.71%	3.47%	2.40%
Return on Common Equity (ROCE)	8.95%	6.70%	4.32%	2.32%	4.80%	7.00%	6.25%	6.18%	7.56%	5.73%
Return on Equity Simple (ROE_SIMPLE)	25.85%	0.00%	4.91%	3.88%	2.97%	0.00%	2.72%	3.49%	4.48%	0.00%
Net Operating Profit after Tax (NOPAT)	11	9.13	5.52	3.57	8.54	12	9.89	11	14	10
NOPAT Margin	6.04%	4.85%	3.05%	1.91%	4.35%	6.29%	5.18%	5.49%	6.73%	5.26%
Net Nonoperating Expense Percent (NNEP)	1.09%	0.51%	0.12%	0.51%	2.26%	3.31%	1.32%	1.27%	1.47%	1.69%
Return On Investment Capital (ROIC_SIMPLE)	-	1.18%	-	-	-	1.34%	-	-	-	1.12%
Cost of Revenue to Revenue	79.32%	79.50%	79.71%	78.58%	77.27%	78.31%	75.40%	73.99%	73.85%	76.48%
SG&A Expenses to Revenue	13.29%	13.82%	14.47%	16.20%	16.40%	16.11%	17.27%	18.31%	17.62%	17.29%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.60%	15.35%	16.78%	18.75%	18.34%	17.04%	17.98%	18.94%	18.57%	18.25%
Earnings before Interest and Taxes (EBIT)	13	12	10	9.06	8.61	9.22	13	14	15	10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	22	22	20	18	20	20	23	24	26	21
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.94	1.15	1.26	0.86	1.00	1.19	1.16	1.30	1.44	1.38
Price to Tangible Book Value (P/TBV)	2.74	3.10	3.30	2.63	2.88	3.38	3.13	3.37	3.59	3.26
Price to Revenue (P/Rev)	0.69	0.85	0.91	0.72	0.84	1.00	0.98	1.10	1.23	1.20
Price to Earnings (P/E)	3.64	21.00	25.64	22.09	33.54	47.71	42.68	37.32	32.18	29.87
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	27.47%	4.76%	3.90%	4.53%	2.98%	2.10%	2.34%	2.68%	3.11%	3.35%
Enterprise Value to Invested Capital (EV/IC)	0.96	1.11	1.18	0.90	1.00	1.14	1.12	1.22	1.33	1.29
Enterprise Value to Revenue (EV/Rev)	1.02	1.13	1.22	1.06	1.17	1.30	1.28	1.40	1.51	1.46
Enterprise Value to EBITDA (EV/EBITDA)	8.66	9.60	10.84	9.50	10.89	12.60	12.13	12.49	12.70	12.17
Enterprise Value to EBIT (EV/EBIT)	15.69	17.82	20.61	17.66	21.94	26.43	24.80	24.49	23.11	21.95
Enterprise Value to NOPAT (EV/NOPAT)	21.31	23.42	27.56	26.54	33.16	34.91	30.30	27.67	26.42	25.72
Enterprise Value to Operating Cash Flow (EV/OCF)	57.22	24.64	27.38	46.89	23.97	31.60	20.27	25.50	27.92	33.53
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	38.82	30.35	77.23
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.49	0.47	0.46	0.45	0.43	0.42	0.41	0.40	0.39	0.36
Long-Term Debt to Equity	0.48	0.46	0.45	0.44	0.42	0.40	0.39	0.38	0.37	0.34
Financial Leverage	0.59	0.41	0.46	0.42	0.41	0.36	0.39	0.38	0.36	0.32
Leverage Ratio	2.11	2.00	1.93	1.88	1.86	1.84	1.82	1.76	1.75	1.70
Compound Leverage Factor	1.58	1.42	1.14	0.69	0.70	0.75	1.26	1.26	1.31	1.11
Debt to Total Capital	32.80%	31.94%	31.71%	30.86%	29.92%	29.39%	28.97%	28.53%	27.85%	26.20%
Short-Term Debt to Total Capital	0.83%	0.81%	0.81%	0.69%	0.69%	0.87%	1.03%	1.19%	1.19%	1.35%
Long-Term Debt to Total Capital	31.97%	31.13%	30.90%	30.17%	29.23%	28.52%	27.94%	27.34%	26.67%	24.85%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	67.20%	68.06%	68.29%	69.14%	70.08%	70.61%	71.03%	71.47%	72.15%	73.80%
Debt to EBITDA	3.05	2.94	2.98	3.35	3.37	3.40	3.26	3.01	2.77	2.57
Net Debt to EBITDA	2.78	2.39	2.77	3.07	3.03	2.85	2.86	2.67	2.37	2.18
Long-Term Debt to EBITDA	2.97	2.87	2.90	3.27	3.29	3.30	3.14	2.88	2.65	2.44
Debt to NOPAT	7.49	7.18	7.58	9.35	10.24	9.42	8.14	6.67	5.75	5.44
Net Debt to NOPAT	6.85	5.84	7.05	8.58	9.22	7.89	7.15	5.92	4.92	4.61
Long-Term Debt to NOPAT	7.31	7.00	7.38	9.14	10.01	9.14	7.85	6.39	5.51	5.16
Altman Z-Score	2.29	2.41	2.56	2.24	2.33	2.56	2.57	2.75	2.95	2.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.75	2.64	2.84	3.16	2.93	2.99	2.99	3.06	3.21	3.24
Quick Ratio	0.64	0.75	0.62	0.71	0.69	0.80	0.72	0.73	0.82	0.84
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-77	-33	-28	-161	-135	-119	-110	-0.47	7.76	-19
Operating Cash Flow to CapEx	-103.61%	605.52%	-353.00%	165.22%	280.03%	759.20%	-33.13%	104.34%	701.31%	508.11%
Free Cash Flow to Firm to Interest Expense	-23.25	0.00	-6.63	0.00	0.00	0.00	-28.39	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-1.67	0.00	-4.49	0.00	0.00	0.00	-0.42	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-3.28	0.00	-5.76	0.00	0.00	0.00	-1.71	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.75	0.71	0.74	0.71	0.71	0.71	0.72	0.69	0.69	0.70
Accounts Receivable Turnover	8.40	8.09	8.18	8.27	7.57	7.26	7.66	7.69	7.36	7.34
Inventory Turnover	3.45	3.53	3.29	3.20	3.06	3.21	2.94	2.91	2.94	2.98
Fixed Asset Turnover	6.41	6.83	6.92	6.86	6.92	6.96	7.00	6.97	7.05	7.11
Accounts Payable Turnover	7.05	7.28	6.70	7.09	7.05	7.31	6.48	7.41	7.65	7.96
Days Sales Outstanding (DSO)	43.47	45.13	44.63	44.11	48.20	50.30	47.67	47.48	49.57	49.75
Days Inventory Outstanding (DIO)	105.67	103.46	111.01	114.17	119.19	113.84	123.95	125.28	124.25	122.67
Days Payable Outstanding (DPO)	51.79	50.17	54.51	51.46	51.76	49.91	56.35	49.28	47.69	45.85
Cash Conversion Cycle (CCC)	97.35	98.43	101.13	106.83	115.63	114.23	115.28	123.49	126.14	126.56
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	736	727	757	877	879	858	877	888	885	888
Invested Capital Turnover	1.00	1.01	0.99	0.94	0.93	0.96	0.94	0.88	0.89	0.90
Increase / (Decrease) in Invested Capital	88	42	33	165	144	131	120	11	5.78	30
Enterprise Value (EV)	706	805	893	788	878	982	980	1,087	1,180	1,146
Market Capitalization	479	605	665	533	634	760	749	854	960	941
Book Value per Share	$42.14	$43.46	$43.50	$50.81	$43.61	$43.58	$43.93	$44.57	$45.13	$46.18
Tangible Book Value per Share	$14.46	$16.14	$16.58	$16.54	$15.11	$15.43	$16.26	$17.21	$18.12	$19.51
Total Capital	757	773	774	900	907	901	909	918	922	925
Total Debt	248	247	245	278	271	265	263	262	257	242
Total Long-Term Debt	242	241	239	271	265	257	254	251	246	230
Net Debt	227	201	228	255	244	222	231	232	220	205
Capital Expenditures (CapEx)	5.30	5.29	5.36	5.56	5.11	3.49	4.97	3.32	1.99	3.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)	303	288	323	345	346	331	353	364	366	368
Debt-free Net Working Capital (DFNWC)	324	334	340	368	373	374	385	394	404	405
Net Working Capital (NWC)	318	328	334	362	367	366	375	383	393	393
Net Nonoperating Expense (NNE)	2.81	1.05	0.29	1.20	5.33	6.99	3.04	3.09	3.40	3.61
Net Nonoperating Obligations (NNO)	227	201	228	255	244	222	231	232	220	205
Total Depreciation and Amortization (D&A)	9.27	10	9.96	8.94	12	10	10	10	11	10
Debt-free, Cash-free Net Working Capital to Revenue	43.91%	40.41%	44.25%	46.45%	45.90%	43.70%	46.01%	46.92%	46.88%	46.78%
Debt-free Net Working Capital to Revenue	47.00%	46.90%	46.60%	49.52%	49.52%	49.36%	50.19%	50.70%	51.65%	51.50%
Net Working Capital to Revenue	46.09%	46.02%	45.74%	48.68%	48.69%	48.33%	48.97%	49.30%	50.25%	49.92%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.70	$0.66	$0.43	$0.18	$0.22	$0.33	$0.47	$0.52	$0.69	$0.45
Adjusted Weighted Average Basic Shares Outstanding	12.11M	12.07M	12.20M	13.40M	14.63M	13.72M	14.69M	14.78M	14.81M	14.77M
Adjusted Diluted Earnings per Share	$0.69	$0.64	$0.42	$0.17	$0.22	$0.33	$0.46	$0.52	$0.67	$0.45
Adjusted Weighted Average Diluted Shares Outstanding	12.35M	12.37M	12.54M	13.60M	14.81M	13.97M	14.94M	14.96M	15.04M	15.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.10M	12.15M	12.24M	14.57M	14.60M	14.64M	14.72M	14.75M	14.78M	14.81M
Normalized Net Operating Profit after Tax (NOPAT)	12	12	9.13	6.97	12	7.51	11	12	15	12
Normalized NOPAT Margin	6.30%	6.30%	5.04%	3.72%	6.28%	3.90%	5.75%	5.98%	7.57%	6.22%
Pre Tax Income Margin	5.32%	4.56%	3.33%	1.78%	1.65%	1.96%	4.58%	5.05%	5.68%	3.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.01	0.00	2.43	0.00	0.00	0.00	3.25	0.00	0.00	0.00
NOPAT to Interest Expense	3.42	0.00	1.31	0.00	0.00	0.00	2.55	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	2.41	0.00	1.16	0.00	0.00	0.00	1.97	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	1.81	0.00	0.04	0.00	0.00	0.00	1.27	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Ducommun's Financials

When does Ducommun's fiscal year end?

According to the most recent income statement we have on file, Ducommun's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ducommun's net income changed over the last 10 years?

Ducommun's net income appears to be on an upward trend, with a most recent value of $31.50 million in 2024, rising from $19.87 million in 2014. The previous period was $15.93 million in 2023.

What is Ducommun's operating income?

Ducommun's total operating income in 2024 was $52.21 million, based on the following breakdown:

Total Gross Profit: $197.27 million
Total Operating Expenses: $145.05 million

How has Ducommun revenue changed over the last 10 years?

Over the last 10 years, Ducommun's total revenue changed from $742.05 million in 2014 to $786.55 million in 2024, a change of 6.0%.

How much debt does Ducommun have?

Ducommun's total liabilities were at $443.57 million at the end of 2024, a 8.5% decrease from 2023, and a 9.7% decrease since 2014.

How much cash does Ducommun have?

In the past 10 years, Ducommun's cash and equivalents has ranged from $0.00 in 2018 to $76.32 million in 2021, and is currently $37.14 million as of their latest financial filing in 2024.

How has Ducommun's book value per share changed over the last 10 years?

Over the last 10 years, Ducommun's book value per share changed from 23.44 in 2014 to 46.18 in 2024, a change of 97.0%.

Remove Ads

Related Companies

This page (NYSE:DCO) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ducommun (DCO) Financials

Frequently Asked Questions About Ducommun's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ducommun (DCO) Financials

Annual Income Statements for Ducommun

Quarterly Income Statements for Ducommun

Annual Cash Flow Statements for Ducommun

Quarterly Cash Flow Statements for Ducommun

Annual Balance Sheets for Ducommun

Quarterly Balance Sheets for Ducommun

Annual Metrics and Ratios for Ducommun

Quarterly Metrics and Ratios for Ducommun

Frequently Asked Questions About Ducommun's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools